Table 2.
Patient Groupa | No; n (Row %) | Yes; n (Row %) | Unknown; n (Row %) | Missing; n (Row %) |
---|---|---|---|---|
Patients in intensive care unit | 7 (39) | 9 (50) | 1 (6) | 1 (6) |
Patients in the emergency room | 10 (56) | 4 (22) | 2 (11) | 2 (11) |
Patients on contact precautions protocol | 16 (89) | 0 (0) | 2 (11) | 0 (0) |
Patients in isolation | 17 (94) | 0 (0) | 0 (0) | 1 (6) |
Patients with immunosuppression | 10 (56) | 5 (28) | 2 (11) | 1 (6) |
Patients in shared rooms | 3 (17) | 10 (56) | 1 (6) | 4 (22) |
Patients who have had a bone marrow transplant | 13 (72) | 4 (22) | 1 (6) | 0 (0) |
Patients with current infections | 14 (78) | 3 (17) | 1 (6) | 0 (0) |
Patients who have open wounds | 12 (67) | 4 (22) | 2 (11) | 0 (0) |
Patients with infections such as MRSA, VRE, ESBL, and CRE | 15 (83) | 0 (0) | 3 (17) | 0 (0) |
Patients colonized by organisms such as MRSA, VRE, ESBL, and CRE | 15 (83) | 0 (0) | 3 (17) | 0 (0) |
Patients with past infections, such as MRSA, VRE, ESBL, and CRE | 7 (39) | 5 (28) | 5 (28) | 1 (6) |
Patients who have recently had surgery | 0 (0) | 16 (89) | 2 (11) | 0 (0) |
Patients who are scheduled for surgery | 2 (11) | 15 (83) | 1 (6) | 0 (0) |
Inpatients | 0 (0) | 18 (100) | 0 (0) | 0 (0) |
Outpatients | 4 (22) | 13 (72) | 0 (0) | 1 (6) |
Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; VRE, vancomycin-resistant enterococcus; ESBL, extended-spectrum β-lactamase; CRE, carbapenem-resistant enterobacteriaceae.
Percentages may not sum to 100% due to rounding.